Neuroscience-focused digital data analysis technology developer IXICO is providing data analytics and neuroimaging services for a late phase clinical research programme in Huntingdon’s disease.
This will generate revenues of £500,000. In the year to September 2018, group revenues were £5.39m. There was £7.86m in the bank at the end of September 2018.
IXICO has been chosen as a partner in the London Medical Imaging and Artificial Intelligence Centre for Value-Based Healthcare. The project is headed up by King’s College and it will develop AI algorithms from NHS medical images and patient data. This will help to speed up diagnosis.
© 2020 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.